LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 47.44K shares, a 309.63% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 7.88K shares, a 81.87% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 75.66K shares, a 41.14% decline from fiscal 2023.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 128.53K shares, a 57.16% decline from fiscal 2022.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 300.04K shares, a 13.87% increase from fiscal 2021.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 263.50K shares, a 51.29% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 75.66K shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 47.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 128.53K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 92.68K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 7.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 92.68K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 73.21K shares 10-Q · filed 2023-05-11 | 128.27K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 11.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 300.04K shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 305.66K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 43.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 403.41K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 244.98K shares 10-Q · filed 2022-05-12 | 445.53K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 17.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 263.50K shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 97.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 246.90K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 85.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | |
| 2021-03-31 | 62.95K shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 600.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 540.93K shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |